CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS)
MASH
CHOLESTASIS
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Embassy of Education CLDF Committees
Embassy of Education
Publications Webcasts Algorithm Abstract Library Committee Members
 
HCC | Abstract Library
Abstract Library
 
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
1.A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response
 

JHEP Rep.?2024 Oct 28;7(2):101252.?doi: 10.1016/j.jhepr.2024.101252.?eCollection 2025 Feb. 

Emilie Crouchet?1,?Nuno Almeida?1,?Sarah C Durand?1,?Marie Parnot?1,?Marine A Oudot?1,?Fabio Giannone?1?2,?Cloé Gadenne?1,?Natascha Roehlen?1,?Antonio Saviano?1?3,?Emanuele Felli?1?4,?Patrick Pessaux?1?5,?Hong Tuan Duong?1,?Hideki Ohdan?6,?Hiroshi Aikata?7,?Kazuaki Chayama?8?9,?Thomas F Baumert?1?3?5?10,?Catherine Schuster?1 
 
2.Radiation Segmentectomy for Early Hepatocellular Carcinoma is Curative
 

J Hepatol. 2025 Jan 22:S0168-8278(25)00011-X. doi: 10.1016/j.jhep.2025.01.005.Online ahead of print.

Riad Salem 1, Siddharth A Padia 2, Beau B Toskich 3, Jon D Callahan 4, Kirk D Fowers 5, Brian S Geller 6, Guy E Johnson 7, Laura Kulik 8, Tushar C Patel 9, Robert J Lewandowski 10, Edward Kim 11
 
3.EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
 

J Hepatol. 2025 Feb;82(2):315-374. doi: 10.1016/j.jhep.2024.08.028.Epub 2024 Dec 17.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver

 
 
4.Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment
 

Clin Liver Dis. 2025 Feb;29(1):125-133. doi: 10.1016/j.cld.2024.08.011.Epub 2024 Oct 20.

Jared Travers 1, Amit Mahipal 2, Pranit Chotai 3, Pierre M Gholam 4
 
5.Synthesising enablers and barriers to hepatocellular carcinoma surveillance-A systematic review of qualitative findings
 

PLoS One. 2025 Jan 10;20(1):e0313216. doi: 10.1371/journal.pone.0313216. eCollection 2025.

Dina Moussa 1 2 3, Joan Ericka Flores 1 2, Joseph S Doyle 3 4, Marno Ryan 2, Jack Wallace 3 5 6, Jessica Howell 1 2 3
 
6.County-Level Food Insecurity and Hepatocellular Carcinoma Risk: A Cross-Sectional Analysis
 

Int J Environ Res Public Health. 2025 Jan 18;22(1):120. doi: 10.3390/ijerph22010120.

Rebecca D Kehm 1 2, Chrystelle L Vilfranc 2, Jasmine A McDonald 1 2, Hui-Chen Wu 2 3
 
7.Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
 

Lancet. 2025 Jan 18;405(10474):216-232.doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8.

Bruno Sangro 1, Masatoshi Kudo 2, Joseph P Erinjeri 3, Shukui Qin 4, Zhenggang Ren 5, Stephen L Chan 6, Yasuaki Arai 7, Jeong Heo 8, Anh Mai 9, Jose Escobar 10, Yamil Alonso Lopez Chuken 11, Jung-Hwan Yoon 12, Won Young Tak 13, Valeriy V Breder 14, Tanita Suttichaimongkol 15, Mohamed Bouattour 16, Shi-Ming Lin 17, Jean-Marie Peron 18, Quang T Nguyen 19, Lunan Yan 20, Chang-Fang Chiu 21, Florinda A Santos 22, Anil Veluvolu 23, Satheesh Chiradoni Thungappa 24, Marco Matos 25, Magdalena Zotkiewicz 26, Stephanie I Udoye 27, John F Kurland 27, Gordon J Cohen 27, Riccardo Lencioni 28; EMERALD-1 Investigators

 

EMERALD-1 Investigators: 

Kathia Abdalla, Manon Allaire, Gustavo Alves, Luis Antunes, Eric Assenat, Sergio Azevedo, Rafael Barreto, Muhammad Beg, Glaucio Bertollo, Jean-Frederic Blanc, Mohamed Bouattour, Rakesh Reddy Boya, Valery Breder, Jean-Pierre Bronowicki, Manoch Buranachokphaisan, Adam Burgoyne, Stephen Chan, Ting-Tsung Chang, Yee Chao, Eric Chen, Xiaoming Chen, Chang-Fang Chiu, Minsig Choi, Sunghee Choi, Natalie Coburn, Luis Contreras, Farshid Dayyani, Thomas Decaens, Arunee Dechaphunkul, Maria Del Consuelo Diaz, Anouk Dev, Jamille Dutra, Melissa Eastgate, Jose Escobar, Bassam Estfan, Vittorio Ferrari, Anne-Claire Frin, Sandip Ganguly, Ranga Raman Ganta, Shanzhi Gu, Yabing Guo, Atsushi Hagihara, Jeong Heo, Chih-Hung Hsu, Jimmy Hwang, Yoshitaka Inaba, Shikha Jain, Derek Jonker, Rajeev L K, Shruti Kate, Naoya Kato, Tomokazu Kawaoka, Kwong-Ming Kee, Seung Up Kim, Kiyohide Kioka, Hironori Koga, Masatoshi Kudo, Hidekatsu Kuroda, Phuong Le, Han-Chu Lee, Joon Hyeok Lee, Teng-Yu Lee, Dongliang Li, Hailiang Li, Wei Li, Xiao Li, Cheng-Yao Lin, Shi-Ming Lin, Yamil Lopez, Ligong Lu, Anh Mai, Konstantin Mamontov, Kunlatida Maneenil, Aleksei Manikhas, Gianluca Masi, Ana Maria Matilla, Marco Matos, Vincenzo Mazzaferro, Zhiqiang Meng, Prabrajya Narayan Mohapatra, Vladimir Moiseyenko, Alejandro Molina, Jose Luis Montero, Manabu Morimoto, Daniel Motola, Guzel Mukhametshina, Hayato Nakagawa, Jean-Charles Nault, Quang Nguyen, Amanda Nicoll, Maria Noriega, Takuji Okusaka, Hideki Onishi, Vikas Sureshchand Ostwal, Jie Pan, Joong-Won Park, Ankit Patel, Rodrigo Perez, Jean-Marie Peron, Shukui Qin, Francisco Ramirez, Zhenggang Ren, Stuart Roberts, Julie Rowe, Yotsawaj Runglodvatana, Bruno Sangro, Florinda Santos, Ravi Kumar Saxena, Guoliang Shao, Anthony Shields, Oksana Shirokova, Aditya Shreenivas, Michele Sisani, Vitalii Skoropad, Simone Strasser, Thatthan Suksombooncharoen, Tanita Suttichaimongkol, Wai Meng Tai, Won Young Tak, Gaojun Teng, Satheesh Chiradoni Thungappa, Nguyen Tran, Son Trinh, Kaoru Tsuchiya, Kunihiko Tsuji, Idoia Ugarteburu, Teerapat Ungtrakul, Gina Vaccaro, Anil Veluvolu, Truc Vo, Yoshiyuki Wada, Alva Weir, Aibing Xu, Lvnan Yan, Jung-Hwan Yoon, Oleg Zarubenkov, Yongyi Zeng, Yonghong Zhang, Ming Zhao, Xin Zheng, Ling Zhu, Xu Zhu
 
8.Disparities in Alcohol-Associated Liver Disease Hospital Encounters Amongst a Texas-Based Cohort of Patients
 

Aliment Pharmacol Ther. 2025 Jan 16. doi: 10.1111/apt.18477. Online ahead of print.

Thomas G Cotter 1, Ahmad Anouti 1, Bill Zhang 2, Elias D Rady 1, Mausam Patel 2, Suraj Patel 1, Daniel J Ellis 1, Sarah R Lieber 1, Nicole E Rich 1, Jacqueline G O'Leary 1, Mack C Mitchell 1, Amit G Singal 1
 
9.DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy
 

J Viral Hepat. 2025 Feb;32(2):e14056. doi: 10.1111/jvh.14056.

Amit G Singal 1, K Rajender Reddy 2, Massimo Colombo 3, Heather L Morris 4, Andrea R Mospan 4, Roniel Cabrera 5, Robin K Kelley 6, Ryan D Kilpatrick 7, Franco Trevisani 8, Fabio Farinati 9, Edoardo G Giannini 10, Neil Mehta 6, Michael W Fried 4, Bruno Sangro 11; DAA-PASS and ITA.LI.CA Investigators
 
10.Surveillance for Hepatocellular Carcinoma
 

Clin Liver Dis. 2025 Feb;29(1):17-31. doi: 10.1016/j.cld.2024.09.001.Epub 2024 Oct 28.

Lewis R Roberts 1
 
11.Systemic Therapy for Hepatocellular Carcinoma
 

Clin Liver Dis. 2025 Feb;29(1):105-124. doi: 10.1016/j.cld.2024.08.010.Epub 2024 Oct 28.

Emily Kinsey 1, Michael A Morse 2
 
12.Hepatic Resection for Hepatocellular Carcinoma
 

Clin Liver Dis. 2025 Feb;29(1):59-72. doi: 10.1016/j.cld.2024.08.008.Epub 2024 Oct 28.

Parissa Tabrizian 1, Adriana Pero 2, Myron Schwartz 3
 
13.Management of Chronic Liver Disease in Patients with Hepatocellular Carcinoma
 

Clin Liver Dis. 2025 Feb;29(1):135-147. doi: 10.1016/j.cld.2024.08.004.Epub 2024 Sep 20.

Zachary H Henry 1, Curtis K Argo 2
 
14.The Role of Palliative Care in the Management of Patients with Hepatocellular Carcinoma
 

Clin Liver Dis. 2025 Feb;29(1):149-156. doi: 10.1016/j.cld.2024.08.005.Epub 2024 Sep 20.

Nabeeha Mohy-Ud-Din 1, Michael Babich 2
 
15.Quality of care in hepatocellular carcinoma-A critical review
 

Hepatol Commun. 2024 Dec 11;9(1):e0595. doi: 10.1097/HC9.0000000000000595.eCollection 2025 Jan 1.

Jonathan Abdelmalak 1 2 3, John S Lubel 1 2, Marie Sinclair 3 4, Ammar Majeed 1 2, William Kemp 1 2, Stuart K Roberts 1 2
 
16.Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis
 

Can Assoc Radiol J. 2024 Dec 29:8465371241306297. doi:10.1177/08465371241306297.Online ahead of print.

Robert G Adamo 1, Eric Lam 2, Jean-Paul Salameh 1, Christian B van der Pol 3, Stacy M Goins 4, Haben Dawit 5, Andreu F Costa 6, Brooke Levis 7, Amit G Singal 8, Victoria Chernyak 9, Claude B Sirlin 10, Mustafa R Bashir 11 12 13, An Tang 14, Ayman Alhasan 15 16, Brian C Allen 17, Caecilia S Reiner 18, Christopher Clarke 19, Daniel R Ludwig 20, Milena Cerny 21, Jin Wang 22, Sang Hyun Choi 23, Tyler J Fraum 20, Bin Song 24, Ijin Joo 25, So Yeon Kim 23, Heejin Kwon 26, Hanyu Jiang 24, Hyo-Jin Kang 27, Andrea S Kierans 28, Yeun-Yoon Kim 29, Maxime Ronot 30, Joanna Podgórska 31, Grzegorz Rosiak 31, Ji Soo Song 32, Matthew D F McInnes 33
 
17.Survival outcomes following liver retransplantation (reSOFT) score: A model predicting survival after adult liver retransplantation
 

Liver Transpl. 2024 Dec 17. doi: 10.1097/LVT.0000000000000549. Online ahead of print.

Vivian Terry 1, Caroline Christmann 2, Spoorthi Kamepalli 3, Ashley Montgomery 3, John Goss 1, Abbas Rana 1
 
18.Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified delphi panel
 

Hepatology. 2024 Dec 18. doi: 10.1097/HEP.0000000000001203. Online ahead of print.

Amit G Singal, Lisa Quirk, Justin Boike, Victoria Chernyak, Ziding Feng, Giamarqo Giamarqo, Fasiha Kanwal, George N Ioannou, Sarah Manes, Jorge A Marrero, Neil Mehta, Anjana Pillai, Nicholas J Shaheen, Aasma Shaukat, Claude B Sirlin, Elizabeth Verna, Sachin Wani, Andrea Wilson Woods, Ju Dong Yang, Neehar D Parikh
 
19.Precision models in hepatocellular carcinoma
 

Nat Rev Gastroenterol Hepatol. 2024 Dec 11. doi: 10.1038/s41575-024-01024-w.Online ahead of print.

Marina Barcena-Varela 1 2 3, Satdarshan P Monga 4 5 6 7, Amaia Lujambio 8 9 10 11
 
20.Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial
 

JAMA Oncol. 2024 Dec 19. doi: 10.1001/jamaoncol.2024.5403. Online ahead of print.

Laura A Dawson 1, Kathryn A Winter 2 3, Jennifer J Knox 1, Andrew X Zhu 4, Sunil Krishnan 5, Chandan Guha 6, Lisa A Kachnic 7, Michael T Gillin 8, Theodore S Hong 4, Timothy D Craig 1, Terence M Williams 9, Ali Hosni 1, Eric Chen 1, Anne M Noonan 10, Eugene J Koay 8, Rishi Sinha 11, Michael I Lock 12, Nitin Ohri 6, Jennifer A Dorth 13, Guila Delouya 14, Anand Swaminath 15, Jennifer Moughan 2 3, Christopher H Crane 16
 
21.Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis
 

JHEP Rep. 2024 Oct 9;7(1):101227. doi: 10.1016/j.jhepr.2024.101227. eCollection 2025 Jan.

Laura Burke 1 2, Alexander Hinkson 1, Vincent Haghnejad 2 3, Rebecca Jones 1, Richard Parker 1, Ian A Rowe 1 2
 
22.Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
 

Gut. 2024 Dec 10:gutjnl-2024-332125. doi: 10.1136/gutjnl-2024-332125.Online ahead of print.

Eleonora De Martin 1 2, Claudia A M Fulgenzi 3, Ciro Celsa 3 4, Astrid Laurent-Bellue 5, Aria Torkpour 3, Pasquale Lombardi 3 6, Antonio D'Alessio 3 7, David J Pinato 3 8
 
23.Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection
 

Abdom Radiol (NY). 2024 Nov 15. doi: 10.1007/s00261-024-04674-1. Online ahead of print.

Karim Seif El Dahan 1, Takeshi Yokoo 1, Mishal Mendiratta-Lala 2, David Fetzer 1, Matthew Davenport 2, Darine Daher 1, Nicole E Rich 1, Edward Yang 1, Neehar D Parikh 2, Amit G Singal 3
 
24.Outcomes After Stereotactic Body Radiation for Hepatocellular Carcinoma in Patients With Child-Pugh A Versus Child-Pugh B/C Cirrhosis
 

Adv Radiat Oncol. 2024 Nov 4;9(12):101631. doi: 10.1016/j.adro.2024.101631.eCollection 2024 Dec.

Brett H Diamond 1, Kara Banson 2, Jonathan Ayash 3, Peter Lee 4, Utkarsh C Shukla 5, Gavin Jones 3, Paul Rava 3, Thomas J Fitzgerald 3, Shirin Sioshansi 3
 
25.Role of immunotherapy in managing cancers prior to liver transplantation
 

Curr Opin Organ Transplant. 2024 Dec 3. doi: 10.1097/MOT.0000000000001187.Online ahead of print.

Philip Bredin 1, Zita Galvin 1 2, Grainne M O'Kane 1 2
 
26.Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA
 

Pharmacoeconomics. 2024 Nov 15. doi: 10.1007/s40273-024-01453-0. Online ahead of print.

Xiaomo Xiong 1, Jeff Jianfei Guo 2
 
27.Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study
 

TherAdvMedOncol. 2024Nov19:16:17588359241297085. doi:10.1177/17588359241297085.eCollection 2024.

Michael Li 1, Lindsay M Hannan 2, Lipika Goyal 3, Andrea G Bocobo 4, Anna L Parks 4, Kelly Bauer 4, Islam Baiev 3, Caroline Dinicola 3, John D Gordan 4, Alan P Venook 4, William P Harris 2, Paige Bracci 4, Robin K Kelley 5
 
28.Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results
 

Expert Opin Emerg Drugs. 2024 Nov 15. doi: 10.1080/14728214.2024.2430493.Online ahead of print.

Leonardo Stella 1 2, Clemence Hollande 3, Yasmina Ben Merabet 3, Hugo Fakhouri 3, Vincent Leclerc 4, Francesca Romana Ponziani 1 5, Mohamed Bouattour 3 6
 
29.Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection
 

J Hepatol. 2024 Dec;81(6):995-1004.doi: 10.1016/j.jhep.2024.06.018. Epub 2024 Jun 24.

Carla Fuster-Anglada 1, Ezequiel Mauro 2, Joana Ferrer-Fàbrega 3, Berta Caballol 4, Marco Sanduzzi-Zamparelli 2, Jordi Bruix 5, Josep Fuster 3, María Reig 5, Alba Díaz 6, Alejandro Forner 7
 
30.Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques
 

J Gastrointest Cancer. 2024 Dec;55(4):1469-1484.doi: 10.1007/s12029-024-01094-8. Epub 2024 Aug 19.

Trinh Nguyen 1, Jaijo Vennatt 2, Lincoln Downs 1, Venkateswar Surabhi 1, Nir Stanietzky 3
 
31.Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study
 

BMJ Open. 2024 Nov 12;14(11):e087373.doi: 10.1136/bmjopen-2024-087373.

Arianna Bellini # 1 2, Marco Finocchietti # 1, Alessandro Cesare Rosa 1, Lucia Masiero 3, Silvia Trapani 3, Massimo Cardillo 3, Marco Massari 4, Stefania Spila Alegiani 5, Silvia Pierobon 6, Eliana Ferroni 6, Martina Zanforlini 7, Olivia Leoni 8, Stefano Ledda 9, Donatella Garau 9, Marina Davoli 1, Antonio Addis 1, Valeria Belleudi 10; CESIT Study Group

Collaborators

  • CESIT Study Group: 

Alessandro C Rosa, Marco Finocchietti, Francesca R Poggi, Maria Lucia Marino, Arianna Bellini, Claudia Marino, Ursula Kirchmayer, Nera Agabiti, Marina Davoli, Antonio Addis, Valeria Belleudi, Marco Massari, Stefania Spila Alegiani, Lucia Masiero, Andrea Ricci, Bedeschi Gaia, Francesca Puoti, Vito Sparacino, Pamela Fiaschetti, Silvia Trapani, Alessandra Oliveti, Daniela Peritore, Massimo Cardillo, Lorella Lombardozzi, Silvia Pierobon, Eliana Ferroni, Maurizio Nordio, Manuel Zorzi, Martina Zanforlini, Arianna Mazzone, Michele Ercolanoni, Giuseppe Piccolo, Andrea Angelo Nisic, Olivia Leoni, Stefano Ledda, Paolo Carta, Donatella Garau, Valentina Ientile, Luca L'Abbate, Matilde Tanaglia, Gianluca Trifirò, Ugo Moretti, Ersilia Lucenteforte
 
32.Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial
 

Gut. 2024 Nov 11;73(12):2037-2044.doi: 10.1136/gutjnl-2024-332508.

Amit G Singal 1, Manasa Narasimman 2, Darine Daher 2, Sruthi Yekkaluri 2, Yan Liu 3, MinJae Lee 4, Vanessa Cerda 2, Aisha Khan 5, Karim Seif El Dahan 2, Jennifer Kramer 5, Purva Gopal 2, Caitlin Murphy 6, Ruben Hernaez 3 7
 
33.Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE
 

ClinResHepatolGastroenterol. 2024Nov13:102496. doi:10.1016/j.clinre.2024.102496.Online ahead of print.

Manon Allaire 1, Hélène Garcia 2, Louis Meyblum 3, Sarah Mouri 4, Eléonore Spitzer 4, Claire Goumard 5, Olivier Lucidarme 2, Marika Rudler 6, Olivier Scatton 5, Charles Roux 3, Mathilde Wagner 2, Dominique Thabut 6
 
34.Forty years of successful national research collaboration in liver disease - the Swedish experience
 

Scand J Gastroenterol. 2024 Nov 1:1-8. doi: 10.1080/00365521.2024.2421824.Online ahead of print.

Annika Bergquist 1, Mattias Ekstedt 2, Hannes Hagström 1, Gunnar Järnerot 3, Stefan Lindgren 4, Emma Nilsson 4, Nils Nyhlin 3, Fredrik Rorsman 5, Per Stål 1, Mårten Werner 6; Swehep; Stergios Kechagias 2
 
35.An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
 

Metabolism. 2024 Nov 19:162:156080. doi: 10.1016/j.metabol.2024.156080.Online ahead of print.

Angelo Armandi 1, Chiara Rosso 2, Gian Paolo Caviglia 3, Elisabetta Bugianesi 4
 
36.Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma
 

Commun Med (Lond). 2024 Dec 3;4(1):258. doi: 10.1038/s43856-024-00677-7.

Mengjun Wang 1, Stephane Grauzam 1 2, Muhammed Furkan Bayram 1, James Dressman 1, Andrew DelaCourt 1, Calvin Blaschke 1, Hongyan Liang 1, Danielle Scott 2, Gray Huffman 2, Alyson Black 3, Shaaron Ochoa-Rios 1, David Lewin 4, Peggi M Angel 1, Richard R Drake 1, Lauren Ball 1, Jennifer Bethard 1, Stephen Castellino 2, Yuko Kono 5, Naoto Kubota 6, Yujin Hoshida 6, Lisa Quirk 6, Adam Yopp 6, Purva Gopal 6, Amit Singal 6, Anand S Mehta 7
 
37.The Influence of Residential Segregation, Urbanicity, and Population Density on Hepatocellular Carcinoma Incidence among a Low Socioeconomic Population
 

Cancer Epidemiol Biomarkers Prev. 2024 Dec 3. doi: 10.1158/1055-9965.EPI-24-1119.Online ahead of print.

Corianne R Johnson 1, Sylvie Muhimpundu 2, Xijing Han 3, Michael T Mumma 4, Martha J Shrubsole 5, Wei Zheng 1, Lucy B Spalluto 1, Loren Lipworth 1, Staci L Sudenga 1
 
38.Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
 

Cancer Epidemiol Biomarkers Prev. 2024 Dec 5. doi: 10.1158/1055-9965.EPI-24-1094.Online ahead of print.

Shyam Patel 1, Mandana Khalili 2, Amit G Singal 3, Paulo S Pinheiro 4, Patricia D Jones 5, Rebecca G Kim 6, Vishwajit Kode 7, Anna Thiemann 7, Wei Zhang 8, Ramsey Cheung 9, Robert J Wong 9
 
39.The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
 

BMC Med. 2024 Dec 3;22(1):574. doi: 10.1186/s12916-024-03802-4.

Matthew Anson 1 2 3, Jun Shang Poon 3, Alex E Henney 1 2 3, David Riley 1 2 3, Gema H Ibarbaru 4, Cyril Sieberhagen 3, Daniel J Cuthbertson 1 2 3, Uazman Alam 1 2 3, Theresa Hydes 5 6 7
 
40.Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study
 

TherAdvMedOncol. 2024Nov19:16:17588359241297085. doi:10.1177/17588359241297085.eCollection 2024.

Michael Li 1, Lindsay M Hannan 2, Lipika Goyal 3, Andrea G Bocobo 4, Anna L Parks 4, Kelly Bauer 4, Islam Baiev 3, Caroline Dinicola 3, John D Gordan 4, Alan P Venook 4, William P Harris 2, Paige Bracci 4, Robin K Kelley 5
 
41.Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results
 

Expert Opin Emerg Drugs. 2024 Nov 15. doi: 10.1080/14728214.2024.2430493.Online ahead of print.

Leonardo Stella 1 2, Clemence Hollande 3, Yasmina Ben Merabet 3, Hugo Fakhouri 3, Vincent Leclerc 4, Francesca Romana Ponziani 1 5, Mohamed Bouattour 3 6
 
42.Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection
 

J Hepatol. 2024 Dec;81(6):995-1004.doi: 10.1016/j.jhep.2024.06.018. Epub 2024 Jun 24.

Carla Fuster-Anglada 1, Ezequiel Mauro 2, Joana Ferrer-Fàbrega 3, Berta Caballol 4, Marco Sanduzzi-Zamparelli 2, Jordi Bruix 5, Josep Fuster 3, María Reig 5, Alba Díaz 6, Alejandro Forner 7
 
43.Ascites as a Predictive Factor in Malignancies in the Last Year of Life-Comparison Between Different Cancer Types
 

J Palliat Med. 2024 Oct 23. doi: 10.1089/jpm.2024.0140. Online ahead of print.
 
44.HCV- and HBV-mediated liver cancer converge on similar transcriptomic landscapes and immune profiles
 

HGG Adv. 2024 Oct 18:100373. doi: 10.1016/j.xhgg.2024.100373. Online ahead of print.

Elizabeth S Borden 1, Annika Jorgensen 2, Heini M Natri 3, Karen Taraszka Hastings 1, Kenneth H Buetow 4, Melissa A Wilson 5
 
45.Cirrhosis in primary practice: many patients remain potentially undiagnosed and are not receiving liver cancer surveillance
 

J Gastroenterol Hepatol. 2024 Oct 24. doi: 10.1111/jgh.16782. Online ahead of print.

David S Prince 1 2 3 4, Shakira Hoque 5, Christy Kim 5, Salim Maher 1 5, Jane Miller 6, Phoebe Chomley 6, Janice Pritchard-Jones 1, Sally Spruce 1, Nathan McGarry 5, David Baker 7, Penelope Elix 8, Ken Liu 1 2 9, Simone I Strasser 1 9, Brendan Goodger 6, Amany Zekry 4 5, Geoffrey W McCaughan 1 2 9
 
46.Functional liver imaging score (FLIS) can predict adverse events in HCC patients
 

Eur J Radiol. 2024 Nov:180:111695. doi: 10.1016/j.ejrad.2024.111695. Epub 2024 Aug 23.

Cesare Maino 1, Fabrizio Romano 2, Paolo Niccolò Franco 3, Antonio Ciaccio 4, Mattia Garancini 5, Cammillo Talei Franzesi 3, Mauro Alessandro Scotti 5, Davide Gandola 3, Alessandro Fogliati 5, Davide Paolo Bernasconi 6, Lorenzo Del Castello 6, Rocco Corso 3, Cristina Ciulli 5, Davide Ippolito 7
 
47.Liver Cancer Etiology: Old Issues and New Perspectives
 

Curr Oncol Rep. 2024 Oct 10. doi: 10.1007/s11912-024-01605-7.Online ahead of print.

Jian-Guo Chen 1, Yong-Hui Zhang 2, Jian-Hua Lu 2, Thomas W Kensler 3
 
48.Tobacco is a Leading Risk Factor for Liver and Extrahepatic Cancers in Patients With Liver Cirrhosis: A Prospective Cohort Study
 

J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101472. doi: 10.1016/j.jceh.2024.101472.Epub 2024 Jun 22.

Iván Herrera 1 2 3, Susana Almenara 2 3 4, Pablo Bellot 1 3 5, Cayetano Miralles 1 3, Maria Rodriguez 1 3, Lucia Gómez-González 6, José M Palazón 1 3, Sonia Pascual 1 3 5, Pedro Zapater 2 3 4 5
 
49.Alcohol and Hepatocellular Carcinoma
 

Clin Liver Dis. 2024 Nov;28(4):633-646.doi: 10.1016/j.cld.2024.06.007.Epub 2024 Jul 23.

Nghiem B Ha 1, Francis Yao 2
 
50.Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision
 

J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101448. doi: 10.1016/j.jceh.2024.101448.Epub 2024 May 22.

Amit G Singal 1, Michelle Ng 1, Anand Kulkarni 2
 
51.Health literacy and cumulative social disadvantage are associated with survival and transplant in patients with hepatocellular carcinoma: a prospective study
 

BMJ Open Gastroenterol. 2024 Oct 2;11(1):e001537. doi: 10.1136/bmjgast-2024-001537.

Lauren D Nephew 1 2, Susan M Rawl 2 3, Allie Carter 4, Nicole Garcia 5, Patrick O Monahan 2 4, John Holden 5, Marwan Ghabril 5, Eleazar Montalvan-Sanchez 6, Kavish Patidar 7, Archita P Desai 5, Eric Orman 5 6, Naga Chalasani 5
 
52.Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques
 

J Gastrointest Cancer. 2024 Dec;55(4):1469-1484.doi: 10.1007/s12029-024-01094-8. Epub 2024 Aug 19.

Trinh Nguyen 1, Jaijo Vennatt 2, Lincoln Downs 1, Venkateswar Surabhi 1, Nir Stanietzky 3
 
53.Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study
 

BMJ Open. 2024 Nov 12;14(11):e087373.doi: 10.1136/bmjopen-2024-087373.

Arianna Bellini # 1 2, Marco Finocchietti # 1, Alessandro Cesare Rosa 1, Lucia Masiero 3, Silvia Trapani 3, Massimo Cardillo 3, Marco Massari 4, Stefania Spila Alegiani 5, Silvia Pierobon 6, Eliana Ferroni 6, Martina Zanforlini 7, Olivia Leoni 8, Stefano Ledda 9, Donatella Garau 9, Marina Davoli 1, Antonio Addis 1, Valeria Belleudi 10; CESIT Study Group

Collaborators

CESIT Study Group: 

Alessandro C Rosa, Marco Finocchietti, Francesca R Poggi, Maria Lucia Marino, Arianna Bellini, Claudia Marino, Ursula Kirchmayer, Nera Agabiti, Marina Davoli, Antonio Addis, Valeria Belleudi, Marco Massari, Stefania Spila Alegiani, Lucia Masiero, Andrea Ricci, Bedeschi Gaia, Francesca Puoti, Vito Sparacino, Pamela Fiaschetti, Silvia Trapani, Alessandra Oliveti, Daniela Peritore, Massimo Cardillo, Lorella Lombardozzi, Silvia Pierobon, Eliana Ferroni, Maurizio Nordio, Manuel Zorzi, Martina Zanforlini, Arianna Mazzone, Michele Ercolanoni, Giuseppe Piccolo, Andrea Angelo Nisic, Olivia Leoni, Stefano Ledda, Paolo Carta, Donatella Garau, Valentina Ientile, Luca L'Abbate, Matilde Tanaglia, Gianluca Trifirò, Ugo Moretti, Ersilia Lucenteforte
 
54.Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial
 

Gut. 2024 Nov 11;73(12):2037-2044.doi: 10.1136/gutjnl-2024-332508.

Amit G Singal 1, Manasa Narasimman 2, Darine Daher 2, Sruthi Yekkaluri 2, Yan Liu 3, MinJae Lee 4, Vanessa Cerda 2, Aisha Khan 5, Karim Seif El Dahan 2, Jennifer Kramer 5, Purva Gopal 2, Caitlin Murphy 6, Ruben Hernaez 3 7
 
55.Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE
 

ClinResHepatolGastroenterol. 2024Nov13:102496. doi:10.1016/j.clinre.2024.102496.Online ahead of print.

Manon Allaire 1, Hélène Garcia 2, Louis Meyblum 3, Sarah Mouri 4, Eléonore Spitzer 4, Claire Goumard 5, Olivier Lucidarme 2, Marika Rudler 6, Olivier Scatton 5, Charles Roux 3, Mathilde Wagner 2, Dominique Thabut 6
 
56.Forty years of successful national research collaboration in liver disease - the Swedish experience
 

Scand J Gastroenterol. 2024 Nov 1:1-8. doi: 10.1080/00365521.2024.2421824.Online ahead of print.

Annika Bergquist 1, Mattias Ekstedt 2, Hannes Hagström 1, Gunnar Järnerot 3, Stefan Lindgren 4, Emma Nilsson 4, Nils Nyhlin 3, Fredrik Rorsman 5, Per Stål 1, Mårten Werner 6; Swehep; Stergios Kechagias 2
 
57.Hepatocellular Carcinoma in Acute Hepatic Porphyria: A Meta-Analysis of Observational Studies
 

Dig Dis Sci. 2024 Oct 22. doi: 10.1007/s10620-024-08661-w. Online ahead of print.

Ashwani K Singal 1 2 3, Rewanth K Reddy 4, Mohan C Gudiwada 5, Jaswant J Jasti 6, Karl E Anderson 7
 
58.Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study
 

Oncology. 2024 Oct 11:1-13. doi: 10.1159/000541018. Online ahead of print.

Mara Persano 1 2, Andrea Casadei-Gardini 3, Toshifumi Tada 4, Goki Suda 5, Shigeo Shimose 6, Masatoshi Kudo 7, Federico Rossari 3 8, Changhoon Yoo 9, Jaekyung Cheon 10, Fabian Finkelmeier 11, Ho Yeong Lim 12, José Presa 13, Gianluca Masi 14 15, Francesca Bergamo 16, Elisabeth Amadeo 3, Francesco Vitiello 3, Takashi Kumada 17, Naoya Sakamoto 5, Hideki Iwamoto 6, Tomoko Aoki 7, Hong Jae Chon 10, Vera Himmelsbach 11, Massimo Alberto Iavarone 18, Giuseppe Cabibbo 19, Margarida Montes 13, Francesco Giuseppe Foschi 20, Caterina Vivaldi 14 15, Caterina Soldà 16, Takuya Sho 5, Takashi Niizeki 6, Naoshi Nishida 7, Christoph Steup 11, Mariangela Bruccoleri 18, Masashi Hirooka 21, Kazuya Kariyama 22, Joji Tani 23, Masanori Atsukawa 24, Koichi Takaguchi 25, Ei Itobayashi 26, Kunihiko Tsuji 27, Toru Ishikawa 28, Kazuto Tajiri 29, Hironori Ochi 30, Satoshi Yasuda 31, Hidenori Toyoda 32, Chikara Ogawa 32, Takashi Nishimura 33, Takeshi Hatanaka 34, Satoru Kakizaki 35, Noritomo Shimada 36, Kazuhito Kawata 37, Atsushi Hiraoka 38, Fujimasa Tada 38, Hideko Ohama 38, Kazuhiro Nouso 22, Asahiro Morishita 23, Akemi Tsutsui 25, Takuya Nagano 25, Norio Itokawa 24, Tomomi Okubo 24, Michitaka Imai 28, Hisashi Kosaka 39, Atsushi Naganuma 40, Yohei Koizumi 21, Shinichiro Nakamura 4, Masaki Kaibori 39, Hiroko Iijima 35, Yoichi Hiasa 21, Luigi Mascia 1, Silvia Foti 3, Silvia Camera 3, Fabio Piscaglia 41, Mario Scartozzi 42, 

59.Cirrhosis in primary practice: many patients remain potentially undiagnosed and are not receiving liver cancer surveillance
 

J Gastroenterol Hepatol. 2024 Oct 24. doi: 10.1111/jgh.16782. Online ahead of print.

David S Prince 1 2 3 4, Shakira Hoque 5, Christy Kim 5, Salim Maher 1 5, Jane Miller 6, Phoebe Chomley 6, Janice Pritchard-Jones 1, Sally Spruce 1, Nathan McGarry 5, David Baker 7, Penelope Elix 8, Ken Liu 1 2 9, Simone I Strasser 1 9, Brendan Goodger 6, Amany Zekry 4 5, Geoffrey W McCaughan 1 2 9
 
60.HCV- and HBV-mediated liver cancer converge on similar transcriptomic landscapes and immune profiles
 

HGG Adv. 2024 Oct 18:100373. doi: 10.1016/j.xhgg.2024.100373. Online ahead of print.

Elizabeth S Borden 1, Annika Jorgensen 2, Heini M Natri 3, Karen Taraszka Hastings 1, Kenneth H Buetow 4, Melissa A Wilson 5
 
61.Ascites as a Predictive Factor in Malignancies in the Last Year of Life-Comparison Between Different Cancer Types
 

J Palliat Med. 2024 Oct 23. doi: 10.1089/jpm.2024.0140. Online ahead of print.
 
62.Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision
 

J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101448. doi: 10.1016/j.jceh.2024.101448.Epub 2024 May 22.

Amit G Singal 1, Michelle Ng 1, Anand Kulkarni 2
 
63.Alcohol and Hepatocellular Carcinoma
 

Clin Liver Dis. 2024 Nov;28(4):633-646.doi: 10.1016/j.cld.2024.06.007.Epub 2024 Jul 23.

Nghiem B Ha 1, Francis Yao 2
 
64.Tobacco is a Leading Risk Factor for Liver and Extrahepatic Cancers in Patients With Liver Cirrhosis: A Prospective Cohort Study
 

J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101472. doi: 10.1016/j.jceh.2024.101472.Epub 2024 Jun 22.

Iván Herrera 1 2 3, Susana Almenara 2 3 4, Pablo Bellot 1 3 5, Cayetano Miralles 1 3, Maria Rodriguez 1 3, Lucia Gómez-González 6, José M Palazón 1 3, Sonia Pascual 1 3 5, Pedro Zapater 2 3 4 5
 
65.Liver Cancer Etiology: Old Issues and New Perspectives
 

Curr Oncol Rep. 2024 Oct 10. doi: 10.1007/s11912-024-01605-7.Online ahead of print.

Jian-Guo Chen 1, Yong-Hui Zhang 2, Jian-Hua Lu 2, Thomas W Kensler 3
 
66.Functional liver imaging score (FLIS) can predict adverse events in HCC patients
 

Eur J Radiol. 2024 Nov:180:111695. doi: 10.1016/j.ejrad.2024.111695. Epub 2024 Aug 23.

Cesare Maino 1, Fabrizio Romano 2, Paolo Niccolò Franco 3, Antonio Ciaccio 4, Mattia Garancini 5, Cammillo Talei Franzesi 3, Mauro Alessandro Scotti 5, Davide Gandola 3, Alessandro Fogliati 5, Davide Paolo Bernasconi 6, Lorenzo Del Castello 6, Rocco Corso 3, Cristina Ciulli 5, Davide Ippolito 7
 
67.Health literacy and cumulative social disadvantage are associated with survival and transplant in patients with hepatocellular carcinoma: a prospective study
 

BMJ Open Gastroenterol. 2024 Oct 2;11(1):e001537. doi: 10.1136/bmjgast-2024-001537.

Lauren D Nephew 1 2, Susan M Rawl 2 3, Allie Carter 4, Nicole Garcia 5, Patrick O Monahan 2 4, John Holden 5, Marwan Ghabril 5, Eleazar Montalvan-Sanchez 6, Kavish Patidar 7, Archita P Desai 5, Eric Orman 5 6, Naga Chalasani 5
 
68.FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis
 

J Clin Gastroenterol. 2024 Oct 1;58(9):917-922. doi: 10.1097/MCG.0000000000001935.

Andrew D Schreiner 1 2, Jingwen Zhang 1 2, William P Moran 1 2, David G Koch 1 2, Justin Marsden 1 2, Sherry Livingston 1 2, Chloe Bays 1 2, Patrick D Mauldin 1 2, Mulugeta Gebregziabher 1 2
 
69.Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER randomized clinical trial
 

Liver Transpl. 2024 Sep 20. doi: 10.1097/LVT.0000000000000487. Online ahead of print.

Federico Piñero 1, Quirino Lai 2, Charlotte Costentin 3, Helena Degroote 4, Andreas Schnitzbauer 5, Edward K Geissler 6, Christophe Duvoux 7; International SilVER Study Group
 
70.The Prognostic Significance of Nativity, Enclave Residence, and Socioeconomic Status Among Hispanic Patients with Hepatocellular Carcinoma
 

Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-15761-4. Online ahead of print.

Zachary A Whitham 1, Nicole M Nevarez 1, Rong Rong 2, Gloria Chang 1, Cecilia G Ethun 1, Matthew R Porembka 1, John C Mansour 1, Sam C Wang 1, Patricio M Polanco 1, Herbert J Zeh 1, Nicole E Rich 3, Amit G Singal 3, Adam C Yopp 4
 
71.Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study
 

Liver Cancer. 2024 Apr 10;13(5):522-536. doi: 10.1159/000537915. eCollection 2024 Oct.

Federico Rossari 1 2, Toshifumi Tada 3, Goki Suda 4, Shigeo Shimose 5, Masatoshi Kudo 6, Changhoon Yoo 7, Jaekyung Cheon 8, Fabian Finkelmeier 9, Ho Yeong Lim 10, José Presa 11, Gianluca Masi 12 13, Francesca Bergamo 14, Elisabeth Amadeo 1, Francesco Vitiello 1, Takashi Kumada 15, Naoya Sakamoto 4, Hideki Iwamoto 5, Tomoko Aoki 6, Hong Jae Chon 8, Vera Himmelsbach 9, Massimo Iavarone 16, Giuseppe Cabibbo 17, Margarida Montes 11, Francesco Giuseppe Foschi 18, Caterina Vivaldi 12 13, Caterina Soldà 14, Takuya Sho 4, Takashi Niizeki 5, Naoshi Nishida 6, Christoph Steup 9, Masashi Hirooka 19, Kazuya Kariyama 20, Joji Tani 21, Masanori Atsukawa 22, Koichi Takaguchi 23, Ei Itobayashi 24, Shinya Fukunishi 25, Kunihiko Tsuji 26, Toru Ishikawa 27, Kazuto Tajiri 28, Hironori Ochi 29, Satoshi Yasuda 30, Hidenori Toyoda 30, Chikara Ogawa 31, Takashi Nishimura 32, Takeshi Hatanaka 33, Satoru Kakizaki 34, Noritomo Shimada 35, Kazuhito Kawata 36, Atsushi Hiraoka 37, Fujimasa Tada 37, Hideko Ohama 37, Kazuhiro Nouso 20, Asahiro Morishita 21, Akemi Tsutsui 23, Takuya Nagano 23, Norio Itokawa 22, Tomomi Okubo 22, Michitaka Imai 27, Hisashi Kosaka 38, Atsushi Naganuma 39, Yohei Koizumi 19, Shinichiro Nakamura 3, Masaki Kaibori 38, Hiroko Iijima 32, Yoichi Hiasa 19, Mara Persano 40, Silvia Foti 1, Silvia Camera 41, Bernardo Stefanini 42, Mario Scartozzi 40, Stefano Cascinu 1, Andrea Casadei-Gardini 1, Margherita Rimini 

72.A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
 

Gastroenterology. 2024Sep16:S00165085(24)05460X. doi:10.1053/j.gastro.2024.09.008.Online ahead of print.

Tracey L Marsh 1, Neehar D Parikh 2, Lewis R Roberts 3, Myron E Schwartz 4, Mindie H Nguyen 5, Alex Befeler 6, Stephanie Page-Lester 1, Nabihah Tayob 7, Sudhir Srivastava 8, Jo Ann Rinaudo 8, Amit G Singal 9, K Rajender Reddy 1, Jorge A Marrero 10
 
73.Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020
 

Cancer Epidemiol. 2024 Oct:92:102610. doi: 10.1016/j.canep.2024.102610. Epub 2024 Jul 9.

Azlann Arnett 1, David A Siegel 2, Shifan Dai 3, Trevor D Thompson 2, Jennifer Foster 1, Erika J di Pierro 1, Behnoosh Momin 2, Philip J Lupo 4, Andras Heczey 5
 
74.Remote Hepatocellular Carcinoma Recurrence to Lumbar Spine Post Orthotopic Liver Transplantation-A Report of Two Cases and a Review of the Literature
 

Transplant Proc. 2024 Sep;56(7):1613-1616.doi:10.1016/j.transproceed.2024.08.017. Epub 2024 Aug 26.

Matthew T Newman 1, Rasham Mittal 2, Dean La Barba 3, Amandeep Sahota 2
 
75.Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
 

Ann Hepatol. 2024 Aug 13:101534. doi: 10.1016/j.aohep.2024.101534. Online ahead of print.

Louisa Stern 1, Constantin Schmidt 2, Lorenz Kocheise 3, Vincent Joerg 3, Christian Casar 4, Aurélie Walter 5, Joost P H Drenth 6, Maria Papp 7, Nikolaos K Gatselis 8, Kalliopi Zachou 9, Matthias Pinter 10, Bernhard Scheiner 10, Arndt Vogel 11, Martha M Kirstein 12, Fabian Finkelmeier 13, Oliver Waidmann 13, Arndt Weinmann 14, Piotr Milkiewicz 15, Douglas Thorburn 16, Neil Halliday 16, Ana Lleo 17, Samuel Huber 2, George N Dalekos 18, Ansgar W Lohse 3, Henning Wege 2, Johann von Felden 3, Kornelius Schulze 3
 
76.STOP-HCV-HCC Program: Privacy-Preserving Innovation for Remote Data Access Analytics at Federally Qualified Health Centers in South Texas
 

Stud Health Technol Inform. 2024 Aug 22:316:1716-1717. doi: 10.3233/SHTI240754.

Catherine K Craven 1, Raudel Bobadilla 1, Edward Yao 1, Caleb Castillo 1, Julio Cerroblanco 1, Bertha E Flores 1, Mamta Jain 2, Alex Radunsky 2, Mikulas Plesak 3, Craig Gentry 3, Riddhiman Das 3, Gharib Gharibi 3
 
77.Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
 

Cancer Epidemiol Biomarkers Prev. 2024 Sep 6. doi: 10.1158/1055-9965.EPI-24-0626.Online ahead of print.

Hannah M Cranford 1, Patricia D Jones 1, Robert J Wong 2, Qinran Liu 3, Erin N Kobetz 4, Isildinha M Reis 5, Tulay Koru-Sengul 1, Paulo S Pinheiro 4
 
78.Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
 

Cancer Lett. 2024 Aug 10:597:217061. doi: 10.1016/j.canlet.2024.217061.Epub 2024 Jun 13.

Lu-Qi Cao 1, Yuhao Xie 2, Joshua S Fleishman 2, Xuan Liu 3, Zhe-Sheng Chen 4
 
79.Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab
 

Sci Rep. 2024 Aug 30;14(1):20200. doi: 10.1038/s41598-024-70928-z.

Margherita Rimini 1 2, Margarida Montes 3, Elisabeth Amadeo 1, Francesco Vitiello 1, Masatoshi Kudo 4, Toshifumi Tada 5, Goki Suda 6, Shigeo Shimose 7, Sara Lonardi 8, Fabian Finkelmeier 9, Francesca Salani 10, Lorenzo Antonuzzo 11 12, Fabio Marra 11, Massimo Iavarone 13, Giuseppe Cabibbo 14, Francesco Giuseppe Foschi 15, Marianna Silletta 16, Rodolfo Sacco 17, Ilario Giovanni Rapposelli 18, Mario Scartozzi 19, Pella Nicoletta 20, Luca Aldrighetti 21, Mara Persano 19, Silvia Camera 19, Federico Rossari 1, Silvia Foti 1, Takashi Kumada 5, Atsushi Hiraoka 5, Hideki Iwamoto 7, Mario Domenico Rizzato 8, Vera Himmelsbach 9, Gianluca Masi 10, Mattia Corradi 13 22, Ciro Celsa 14, Conti Fabio 15, Giovanni Luca Frassineti 18, Stefano Cascinu 1 2, Andrea Casadei-Gardini 23 24, Jose Presa 3
 
80.Clinical implications of inflammation in patients with cirrhosis
 

Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003056. Online ahead of print.

Victoria T Kronsten 1 2, Debbie L Shawcross 1 2
 
81.STOP-HCV-HCC Program: Privacy-Preserving Innovation for Remote Data Access Analytics at Federally Qualified Health Centers in South Texas
 

Stud Health Technol Inform. 2024 Aug 22:316:1716-1717. doi: 10.3233/SHTI240754.

Catherine K Craven 1, Raudel Bobadilla 1, Edward Yao 1, Caleb Castillo 1, Julio Cerroblanco 1, Bertha E Flores 1, Mamta Jain 2, Alex Radunsky 2, Mikulas Plesak 3, Craig Gentry 3, Riddhiman Das 3, Gharib Gharibi 3
 
82.Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
 

Ann Hepatol. 2024 Aug 13:101534. doi: 10.1016/j.aohep.2024.101534. Online ahead of print.

Louisa Stern 1, Constantin Schmidt 2, Lorenz Kocheise 3, Vincent Joerg 3, Christian Casar 4, Aurélie Walter 5, Joost P H Drenth 6, Maria Papp 7, Nikolaos K Gatselis 8, Kalliopi Zachou 9, Matthias Pinter 10, Bernhard Scheiner 10, Arndt Vogel 11, Martha M Kirstein 12, Fabian Finkelmeier 13, Oliver Waidmann 13, Arndt Weinmann 14, Piotr Milkiewicz 15, Douglas Thorburn 16, Neil Halliday 16, Ana Lleo 17, Samuel Huber 2, George N Dalekos 18, Ansgar W Lohse 3, Henning Wege 2, Johann von Felden 3, Kornelius Schulze 3
 
83.Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
 

JCO Clin Cancer Inform. 2024 Aug:8:e2300220. doi: 10.1200/CCI.23.00220.

Timothy J Brown 1 2, Phyllis A Gimotty 3, Ronac Mamtani 2, Thomas B Karasic 2, Yu-Xiao Yang 4 5
 
84.Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases
 

Biomolecules. 2024 Jul 12;14(7):841. doi: 10.3390/biom14070841.

Josh Bilson 1 2, Eleonora Scorletti 1 2 3, Jonathan R Swann 1 2, Christopher D Byrne 1 2
 
85.Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
 

Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001026. Online ahead of print.

Ciro Celsa 1 2, Giuseppe Cabibbo 2, Claudia Angela Maria Fulgenzi 1, Salvatore Battaglia 3, Marco Enea 4, Bernhard Scheiner 5, Antonio D'Alessio 1 6, Giulia F Manfredi 1 6, Bernardo Stefanini 1 7, Naoshi Nishida 8, Peter R Galle 9, Kornelius Schulze 10, Henning Wege 10, Roberta Ciccia 2, Wei-Fan Hsu 11, Caterina Vivaldi 12, Brooke Wietharn 13, Ryan Po-Ting Lin 14 15, Angelo Pirozzi 16 17, Tiziana Pressiani 17, Andrea Dalbeni 18 19, Leonardo A Natola 19, Alessandra Auriemma 20, Cristina Rigamonti 6, Michela Burlone 6, Alessandro Parisi 21, Yi-Hsiang Huang 22 23 24, Pei-Chang Lee 23 25, Celina Ang 26, Thomas U Marron 27, Matthias Pinter 5, Jaekyung Cheon 27, Samuel Phen 28, Amit G Singal 28, Anuhya Gampa 29, Anjana Pillai 29, Natascha Roehlen 30, Robert Thimme 30, Arndt Vogel 31 32, Noha Soror 33, Susanna Ulahannan 33, Rohini Sharma 1, David Sacerdoti 19, Mario Pirisi 6, Lorenza Rimassa 16 17, Chun-Yen Lin 14 15, Anwaar Saeed 34, Gianluca Masi 12, Martin Schönlein 35, Johann von Felden 10, Masatoshi Kudo 8, Alessio Cortellini 1 36, Hong Jae Chon 27, Calogero Cammà 2, David James Pinato 1 6
 
86.Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC
 

Clin Gastroenterol Hepatol. 2024 Jul 30:S1542-3565(24)00678-5.doi: 10.1016/j.cgh.2024.07.008. Online ahead of print.

Neehar D Parikh 1, Patricia Jones 2, Reena Salgia 3, Irun Bhan 4, Lauren T Grinspan 5, Janice H Jou 6, Kali Zhou 7, Prasun Jalal 8, Giorgio Roccaro 9, Amol S Rangnekar 10, Jihane N Benhammou 11, Anjana Pillai 12, Neil Mehta 13, Joel Wedd 14, Ju Dong Yang 15, Amy K Kim 16, Andres Duarte-Rojo 17, Omobonike O Oloruntoba 18, Amit Tevar 19, Jennifer S Au 20, Yamile Blain 2, Sanjana Rao 2, Onofrio A Catalano 4, Sara Lewis 5, Mishal Mendiratta-Lala 21, Kevin King 7, Lekha Sachdev 10, Edward W Lee 11, Jill Bruno 14, Ihab Kamel 16, Celestina Tolosa 16, Karissa Kao 21, Tarek Badawi 3, Eric M Przybyszewski 4, Lisa Quirk 22, Piyush Nathani 22, Brandy Haydel 5, Emily Leven 5, Nicole Wong 6, Robert Albertian 7, Ariana Chen 7, Fuad Z Aloor 8, Islam B Mohamed 8, Ahmed Elkheshen 8, Charles Marvil 9, Gerard Issac 9, Joseph W Clinton 10, Stephanie M Woo 10, Jung Yum 11, Erin Rieger 12, Alan L Hutchison 12, Don A Turner 14, Manaf Alsudaney 15, Perla Hernandez 15, Ziyi Xu 16, Abdullah Khalid 20, Bethany Barrick 20, Bo Wang 21, Elliot B Tapper 21, Wei Hao 21, Amit G Singal 22
 
87.Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
 

AMA Oncol. 2024 Jul 18:e242166.doi: 10.1001/jamaoncol.2024.2166. Online ahead of print.

Claudia Angela Maria Fulgenzi 1 2, Bernhard Scheiner 1 3, Antonio D'Alessio 1 4, Aman Mehan 1, Giulia F Manfredi 1 4, Ciro Celsa 1 5, Naoshi Nishida 6, Celina Ang 7, Thomas U Marron 7, Linda Wu 7, Anwaar Saeed 8, Brooke Wietharn 8, Antonella Cammarota 9 10, Tiziana Pressiani 10, Matthias Pinter 3, Rohini Sharma 1, Jaekyung Cheon 11, Yi-Hsiang Huang 12 13 14, Pei-Chang Lee 13 15, Samuel Phen 16, Anuhya Gampa 17, Anjana Pillai 18, Andrea Napolitano 19, Caterina Vivaldi 20, Francesca Salani 20 21, Gianluca Masi 20, Marianna Silletta 2, Federica Lo Prinzi 2, Emanuela Di Giacomo 2, Bruno Vincenzi 2, Dominik Bettinger 22, Robert Thimme 22, Arndt Vogel 23, Martin Schönlein 24, Johann von Felden 25, Kornelius Schulze 25, Henning Wege 25, Peter R Galle 26, Mario Pirisi 4, Joong-Won Park 27, Masatoshi Kudo 6, Lorenza Rimassa 9 10, Amit G Singal 13 15, Paul El Tomb 28, Susanna Ulahannan 28, Alessandro Parisi 29, Hong Jae Chon 11, Wei-Fan Hsu 30, Giorgia Ghittoni 31, Calogero Cammà 5, Benedetta Stefanini 32, Franco Trevisani 32, Edoardo G Giannini 33 34, Alessio Cortellini 1 2, David James Pinato 1 4
 
88.The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints
 

Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002953. Online ahead of print.

Elliot B Tapper 1, David Goldberg 2, Neehar D Parikh 1, Norah A Terrault 3, Nicole Welch 4, Suzanne Sharpton 5, Bilal Hameed 6, Mandana Khalili 6, Andrew Stolz 3, Elizabeth C Verna 7, Robert S Brown Jr 8, Arun J Sanyal 9, Lisa VanWagner 10, Daniela P Ladner 11, Cynthia A Moylan 12, Anna Mae Diehl 12, Patricia D Jones 2, Rohit C Loomba 5, Srinivasan Dasarathy 4, Douglas A Simonetto 13, Vijay H Shah 13, Jasmohan S Bajaj 9; LCN Study Group
 
89.British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults
 

Gut. 2024 Jul 11;73(8):1235-1268. doi: 10.1136/gutjnl-2023-331695.

Abid Suddle 1, Helen Reeves 2, Richard Hubner 3, Aileen Marshall 4, Ian Rowe 5 6, Dina Tiniakos 7, Stefan Hubscher 8, Mark Callaway 9, Dinesh Sharma 10, Teik Choon See 11, Maria Hawkins 12, Suzanne Ford-Dunn 13, Sarah Selemani 14, Tim Meyer 15
 
90.Etiology-independent activation of the LTß-LTßR-RELB axis drives aggressiveness and predicts poor prognosis in HCC
 

Hepatology. 2024 Aug 1;80(2):278-294. doi: 10.1097/HEP.0000000000000657.Epub 2023 Nov 2.

Anna-Lena Scherr 1, Luisa Nader 1, Kaiyu Xu 1, Christin Elssner 1, Dirk A Ridder 2, Federico Nichetti 3 4, Manuel Mastel 5 6, Sarah Fritzsche 7, Eblina Kelmendi 1, Nathalie Schmitt 1, Paula Hoffmeister-Wittmann 1 8, Sofia M E Weiler 7, Felix Korell 9 10, Thomas Albrecht 7 11, Maximilian Schwab 1, Hanna Isele 1, Annika Kessler 1, Jennifer Hüllein 4, Agnieszka Seretny 12, Liangtao Ye 13, Toni Urbanik 1, Stefan Welte 1 8, Anne-Laure Leblond 14, Christoph E Heilig 9 15, Mohammad Rahbari 16, Adnan Ali 16, Suchira Gallage 16, Bénédicte Lenoir 17, Nina Wilhelm 17, Ulrike Gärtner 18, Simon J Ogrodnik 19, Christoph Springfeld 1 11, Darjus Tschaharganeh 7 12, Stefan Fröhling 9 15, Thomas Longerich 7, Henning Schulze-Bergkamen 20, Dirk Jäger 1, Lydia Brandl 21, Peter Schirmacher 7 11, Beate K Straub 2, Achim Weber 14, Enrico N De Toni 13, Benjamin Goeppert 7 11, Mathias Heikenwalder 16 22, Rene Jackstadt 5 6, Stephanie Roessler 7 11, Kai Breuhahn 7 11, Bruno C Köhler 1 9 11
 
91.The Trends in Health Care Utilization and Costs Associated With Primary Liver Cancer: An Analysis of United States Hospitals Between 2016 and 2019
 

J Clin Gastroenterol. 2024 Aug 1;58(7):726-736. doi: 10.1097/MCG.0000000000001927.

David U Lee 1, Elyse A Adonizio 2, David J Hastie 2, Reid Ponder 2, Ki Jung Lee 2, Daniel Jung 3, Gregory H Fan 2, Raza Malik 4
 
92.A study comparing the cost-effectiveness of conventional and drug-eluting transarterial chemoembolisation (cTACE and DEB-TACE) for the treatment of hepatocellular carcinoma in an Australian public hospital
 

J Med Imaging Radiat Oncol. 2024 Jul 10. doi: 10.1111/1754-9485.13731.Online ahead of print.

Warren Clements 1 2 3, Abigail Chenoweth 1, Benjamin Phipps 1, Lowella Mozo 1, Mark Bolger 1, Laura Morphett 4, Tuan Phan 1 2, Jim Koukounaras 1 2, Matthew W Lukies 1 2 5
 
93.Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study
 

Oncologist. 2024 Jul 9:oyae142. doi: 10.1093/oncolo/oyae142. Online ahead of print.

Michael H Storandt 1, Tyler J Zemla MS 2, Kanchi Patell 3, Nikolas Naleid 4, Jennifer J Gile 5, Nguyen H Tran 5, Sakti Chakrabarti 3, Zhaohui Jin 5, Mitesh Borad 6, Amit Mahipal 3
 
94.Impact of DAA Treatment for HCV on Hepatocellular Carcinoma in a Predominately African American Population
 

J Gastrointest Cancer. 2024 Jul 8. doi: 10.1007/s12029-024-01076-w. Online ahead of print.

Mohamad I Itani 1, Bassem Farah 1, Margaret Wasvary 1, Anshu Wadehra 1, Tj Wilson 1, Brian Rutledge 1, Paul Naylor 2, Eliza W Beal 3, Milton Mutchnick 1
 
95.Global prevalence, clinical characteristics, surveillance, treatment allocation, and outcomes of alcohol-associated hepatocellular carcinoma
 

 

ClinGastroenterolHepatol. 2024Jul8:S15423565(24)006013.doi:10.1016/j.cgh.2024.06.026. Online ahead of print.

Rebecca Wenling Zeng 1, Christen En Ya Ong 1, Elden Yen Hng Ong 1, Charlotte Hui Chung 1, Wen Hui Lim 1, Jieling Xiao 1, Pojsakorn Danpanichkul 2, Jia Hao Law 3, Nicholas Syn 4, Douglas Chee 5, Alfred Wei Chieh Kow 6, Sung Won Lee 7, Hirokazu Takahashi 8, Takumi Kawaguchi 9, Nobuharu Tamaki 10, Yock Young Dan 11, Atsushi Nakajima 12, Karn Wijarnpreecha 13, Mark D Muthiah 11, Mazen Noureddin 14, Rohit Loomba 15, George N Ioannou 16, Darren Jun Hao Tan 1, Cheng Han Ng 17, Daniel Q Huang 18

 
 
96.ACG Clinical Guideline: Focal Liver Lesions
 

Am J Gastroenterol. 2024 Jul 1;119(7):1235-1271.doi: 10.14309/ajg.0000000000002857. Epub 2024 Jan 26.

Catherine Frenette 1, Mishal Mendiratta-Lala 2, Reena Salgia 3, Robert J Wong 4, Bryan G Sauer 5, Anjana Pillai 6
 
97.Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
 

JCO Clin Cancer Inform. 2024 Aug:8:e2300220. doi: 10.1200/CCI.23.00220.

 

Timothy J Brown 1 2, Phyllis A Gimotty 3, Ronac Mamtani 2, Thomas B Karasic 2, Yu-Xiao Yang 4 5
 
98.Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases
 

Biomolecules. 2024 Jul 12;14(7):841. doi: 10.3390/biom14070841.

 

Josh Bilson 1 2, Eleonora Scorletti 1 2 3, Jonathan R Swann 1 2, Christopher D Byrne 1 2
 
99.Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
 

Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001026. Online ahead of print.

 

Ciro Celsa 1 2, Giuseppe Cabibbo 2, Claudia Angela Maria Fulgenzi 1, Salvatore Battaglia 3, Marco Enea 4, Bernhard Scheiner 5, Antonio D'Alessio 1 6, Giulia F Manfredi 1 6, Bernardo Stefanini 1 7, Naoshi Nishida 8, Peter R Galle 9, Kornelius Schulze 10, Henning Wege 10, Roberta Ciccia 2, Wei-Fan Hsu 11, Caterina Vivaldi 12, Brooke Wietharn 13, Ryan Po-Ting Lin 14 15, Angelo Pirozzi 16 17, Tiziana Pressiani 17, Andrea Dalbeni 18 19, Leonardo A Natola 19, Alessandra Auriemma 20, Cristina Rigamonti 6, Michela Burlone 6, Alessandro Parisi 21, Yi-Hsiang Huang 22 23 24, Pei-Chang Lee 23 25, Celina Ang 26, Thomas U Marron 27, Matthias Pinter 5, Jaekyung Cheon 27, Samuel Phen 28, Amit G Singal 28, Anuhya Gampa 29, Anjana Pillai 29, Natascha Roehlen 30, Robert Thimme 30, Arndt Vogel 31 32, Noha Soror 33, Susanna Ulahannan 33, Rohini Sharma 1, David Sacerdoti 19, Mario Pirisi 6, Lorenza Rimassa 16 17, Chun-Yen Lin 14 15, Anwaar Saeed 34, Gianluca Masi 12, Martin Schönlein 35, Johann von Felden 10, Masatoshi Kudo 8, Alessio Cortellini 1 36, Hong Jae Chon 27, Calogero Cammà 2, David James Pinato 1 6
 
100.Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC
 

Clin Gastroenterol Hepatol. 2024 Jul 30:S1542-3565(24)00678-5.doi: 10.1016/j.cgh.2024.07.008. Online ahead of print.

 

Neehar D Parikh 1, Patricia Jones 2, Reena Salgia 3, Irun Bhan 4, Lauren T Grinspan 5, Janice H Jou 6, Kali Zhou 7, Prasun Jalal 8, Giorgio Roccaro 9, Amol S Rangnekar 10, Jihane N Benhammou 11, Anjana Pillai 12, Neil Mehta 13, Joel Wedd 14, Ju Dong Yang 15, Amy K Kim 16, Andres Duarte-Rojo 17, Omobonike O Oloruntoba 18, Amit Tevar 19, Jennifer S Au 20, Yamile Blain 2, Sanjana Rao 2, Onofrio A Catalano 4, Sara Lewis 5, Mishal Mendiratta-Lala 21, Kevin King 7, Lekha Sachdev 10, Edward W Lee 11, Jill Bruno 14, Ihab Kamel 16, Celestina Tolosa 16, Karissa Kao 21, Tarek Badawi 3, Eric M Przybyszewski 4, Lisa Quirk 22, Piyush Nathani 22, Brandy Haydel 5, Emily Leven 5, Nicole Wong 6, Robert Albertian 7, Ariana Chen 7, Fuad Z Aloor 8, Islam B Mohamed 8, Ahmed Elkheshen 8, Charles Marvil 9, Gerard Issac 9, Joseph W Clinton 10, Stephanie M Woo 10, Jung Yum 11, Erin Rieger 12, Alan L Hutchison 12, Don A Turner 14, Manaf Alsudaney 15, Perla Hernandez 15, Ziyi Xu 16, Abdullah Khalid 20, Bethany Barrick 20, Bo Wang 21, Elliot B Tapper 21, Wei Hao 21, Amit G Singal 22
 
101.Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
 

AMA Oncol. 2024 Jul 18:e242166.doi: 10.1001/jamaoncol.2024.2166. Online ahead of print.

 

Claudia Angela Maria Fulgenzi 1 2, Bernhard Scheiner 1 3, Antonio D'Alessio 1 4, Aman Mehan 1, Giulia F Manfredi 1 4, Ciro Celsa 1 5, Naoshi Nishida 6, Celina Ang 7, Thomas U Marron 7, Linda Wu 7, Anwaar Saeed 8, Brooke Wietharn 8, Antonella Cammarota 9 10, Tiziana Pressiani 10, Matthias Pinter 3, Rohini Sharma 1, Jaekyung Cheon 11, Yi-Hsiang Huang 12 13 14, Pei-Chang Lee 13 15, Samuel Phen 16, Anuhya Gampa 17, Anjana Pillai 18, Andrea Napolitano 19, Caterina Vivaldi 20, Francesca Salani 20 21, Gianluca Masi 20, Marianna Silletta 2, Federica Lo Prinzi 2, Emanuela Di Giacomo 2, Bruno Vincenzi 2, Dominik Bettinger 22, Robert Thimme 22, Arndt Vogel 23, Martin Schönlein 24, Johann von Felden 25, Kornelius Schulze 25, Henning Wege 25, Peter R Galle 26, Mario Pirisi 4, Joong-Won Park 27, Masatoshi Kudo 6, Lorenza Rimassa 9 10, Amit G Singal 13 15, Paul El Tomb 28, Susanna Ulahannan 28, Alessandro Parisi 29, Hong Jae Chon 11, Wei-Fan Hsu 30, Giorgia Ghittoni 31, Calogero Cammà 5, Benedetta Stefanini 32, Franco Trevisani 32, Edoardo G Giannini 33 34, Alessio Cortellini 1 

 
102.The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints
 

Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002953. Online ahead of print.

 

Elliot B Tapper 1, David Goldberg 2, Neehar D Parikh 1, Norah A Terrault 3, Nicole Welch 4, Suzanne Sharpton 5, Bilal Hameed 6, Mandana Khalili 6, Andrew Stolz 3, Elizabeth C Verna 7, Robert S Brown Jr 8, Arun J Sanyal 9, Lisa VanWagner 10, Daniela P Ladner 11, Cynthia A Moylan 12, Anna Mae Diehl 12, Patricia D Jones 2, Rohit C Loomba 5, Srinivasan Dasarathy 4, Douglas A Simonetto 13, Vijay H Shah 13, Jasmohan S Bajaj 9; LCN Study Group
 
103.British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults
 

Gut. 2024 Jul 11;73(8):1235-1268. doi: 10.1136/gutjnl-2023-331695.

 

Abid Suddle 1, Helen Reeves 2, Richard Hubner 3, Aileen Marshall 4, Ian Rowe 5 6, Dina Tiniakos 7, Stefan Hubscher 8, Mark Callaway 9, Dinesh Sharma 10, Teik Choon See 11, Maria Hawkins 12, Suzanne Ford-Dunn 13, Sarah Selemani 14, Tim Meyer 15
 
104.Etiology-independent activation of the LTß-LTßR-RELB axis drives aggressiveness and predicts poor prognosis in HCC
 

Hepatology. 2024 Aug 1;80(2):278-294. doi: 10.1097/HEP.0000000000000657.Epub 2023 Nov 2.

 

Anna-Lena Scherr 1, Luisa Nader 1, Kaiyu Xu 1, Christin Elssner 1, Dirk A Ridder 2, Federico Nichetti 3 4, Manuel Mastel 5 6, Sarah Fritzsche 7, Eblina Kelmendi 1, Nathalie Schmitt 1, Paula Hoffmeister-Wittmann 1 8, Sofia M E Weiler 7, Felix Korell 9 10, Thomas Albrecht 7 11, Maximilian Schwab 1, Hanna Isele 1, Annika Kessler 1, Jennifer Hüllein 4, Agnieszka Seretny 12, Liangtao Ye 13, Toni Urbanik 1, Stefan Welte 1 8, Anne-Laure Leblond 14, Christoph E Heilig 9 15, Mohammad Rahbari 16, Adnan Ali 16, Suchira Gallage 16, Bénédicte Lenoir 17, Nina Wilhelm 17, Ulrike Gärtner 18, Simon J Ogrodnik 19, Christoph Springfeld 1 11, Darjus Tschaharganeh 7 12, Stefan Fröhling 9 15, Thomas Longerich 7, Henning Schulze-Bergkamen 20, Dirk Jäger 1, Lydia Brandl 21, Peter Schirmacher 7 11, Beate K Straub 2, Achim Weber 14, Enrico N De Toni 13, Benjamin Goeppert 7 11, Mathias Heikenwalder 16 22, Rene Jackstadt 5 6, Stephanie Roessler 7 11, Kai Breuhahn 7 11, Bruno C Köhler 1 9 11
 
105.The Trends in Health Care Utilization and Costs Associated With Primary Liver Cancer: An Analysis of United States Hospitals Between 2016 and 2019
 

J Clin Gastroenterol. 2024 Aug 1;58(7):726-736. doi: 10.1097/MCG.0000000000001927.

 

David U Lee 1, Elyse A Adonizio 2, David J Hastie 2, Reid Ponder 2, Ki Jung Lee 2, Daniel Jung 3, Gregory H Fan 2, Raza Malik 4
 
106.A study comparing the cost-effectiveness of conventional and drug-eluting transarterial chemoembolisation (cTACE and DEB-TACE) for the treatment of hepatocellular carcinoma in an Australian public hospital
 

J Med Imaging Radiat Oncol. 2024 Jul 10. doi: 10.1111/1754-9485.13731.Online ahead of print.

 

Warren Clements 1 2 3, Abigail Chenoweth 1, Benjamin Phipps 1, Lowella Mozo 1, Mark Bolger 1, Laura Morphett 4, Tuan Phan 1 2, Jim Koukounaras 1 2, Matthew W Lukies 1 2 5
 
107.Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study
 

Oncologist. 2024 Jul 9:oyae142. doi: 10.1093/oncolo/oyae142. Online ahead of print.

 

Michael H Storandt 1, Tyler J Zemla MS 2, Kanchi Patell 3, Nikolas Naleid 4, Jennifer J Gile 5, Nguyen H Tran 5, Sakti Chakrabarti 3, Zhaohui Jin 5, Mitesh Borad 6, Amit Mahipal 3
 
108.Impact of DAA Treatment for HCV on Hepatocellular Carcinoma in a Predominately African American Population
 

J Gastrointest Cancer. 2024 Jul 8. doi: 10.1007/s12029-024-01076-w. Online ahead of print.

 

Mohamad I Itani 1, Bassem Farah 1, Margaret Wasvary 1, Anshu Wadehra 1, Tj Wilson 1, Brian Rutledge 1, Paul Naylor 2, Eliza W Beal 3, Milton Mutchnick 1
 
109.Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH
 

Transplant Direct. 2024 Jun 20;10(7):e1642. doi: 10.1097/TXD.0000000000001642.eCollection 2024 Jul.

 

Jia Hong Koh 1, Douglas Chee 1, Cheng Han Ng 1, Karn Wijarnpreecha 2, Mark Muthiah 1 2, Darren Jun Hao Tan 3, Wen Hui Lim 3, Rebecca Wenling Zeng 3, Benjamin Koh 3, Eunice Tan Xiang Xuan 1, Glenn Bonney 4, Shridhar Iyer 4, Dan Yock Young 1, Toru Nakamura 5, Hirokazu Takahashi 6, Mazen Noureddin 7, Mohammad Shadab Siddiqui 8, Tracey G Simon 9, Rohit Loomba 10, Daniel Q Huang 11
 
110.Global prevalence, clinical characteristics, surveillance, treatment allocation, and outcomes of alcohol-associated hepatocellular carcinoma
 

ClinGastroenterolHepatol. 2024Jul8:S15423565(24)006013.doi:10.1016/j.cgh.2024.06.026. Online ahead of print.

 

Rebecca Wenling Zeng 1, Christen En Ya Ong 1, Elden Yen Hng Ong 1, Charlotte Hui Chung 1, Wen Hui Lim 1, Jieling Xiao 1, Pojsakorn Danpanichkul 2, Jia Hao Law 3, Nicholas Syn 4, Douglas Chee 5, Alfred Wei Chieh Kow 6, Sung Won Lee 7, Hirokazu Takahashi 8, Takumi Kawaguchi 9, Nobuharu Tamaki 10, Yock Young Dan 11, Atsushi Nakajima 12, Karn Wijarnpreecha 13, Mark D Muthiah 11, Mazen Noureddin 14, Rohit Loomba 15, George N Ioannou 16, Darren Jun Hao Tan 1, Cheng Han Ng 17, Daniel Q Huang 18
 
111.Imageable Radioembolization Microspheres for Treatment of Unresectable Hepatocellular Carcinoma: Interim Results from a First-in-Human Trial
 

J Vasc Interv Radiol. 2024 Jun 27:S10510443(24)004366. doi:10.1016/j.jvir.2024.06.023.Online ahead of print.

 

Robert J Abraham 1, Aravind Arepally 2, David Liu 3, Robert Lewandowski 4, S Cheenu Kappadath 5, Amit Verma 6, David Dobrowski 6, Andrew Holden 7
 
112.ACG Clinical Guideline: Focal Liver Lesions
 

Am J Gastroenterol. 2024 Jul 1;119(7):1235-1271.doi: 10.14309/ajg.0000000000002857. Epub 2024 Jan 26.

 

Catherine Frenette 1, Mishal Mendiratta-Lala 2, Reena Salgia 3, Robert J Wong 4, Bryan G Sauer 5, Anjana Pillai 6
 
113.Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
 

Curr Opin Virol. 2024 Jun 25:67:101423. doi: 10.1016/j.coviro.2024.101423.Online ahead of print.

 

Felix Fiehn 1, Claudia Beisel 2, Marco Binder 3
 
114.Consensus statement on safety of combining transarterial radioembolization with 90yttrium microspheres with systemic anticancer agents for the treatment of liver malignancy
 

J Vasc Interv Radiol. 2024 Jun 15:S10510443(24)003981.doi:10.1016/j.jvir.2024.06.006. Online ahead of print.

 

Andrew S Kennedy 1, Daniel B Brown 2, Marwan Fakih 3, Rohan Jeyarajah 4, Suzanne Jones 5, David Liu 6, David J Pinato 7, Bruno Sangro 8, Navesh K Sharma 9, Daniel Y Sze 10, Eric Van Cutsem 11, Harpreet S Wasan 12
 
115.Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma
 

Liver Int. 2024 Jul;44(7):1588-1599. doi: 10.1111/liv.15855. Epub 2024 Mar 1.

 

Edoardo G Giannini 1 2, Andrea Pasta 1 2, Giulia Pieri 1 2, Maria Corina Plaz Torres 1 2, Mariarosaria Marseglia 3 4, Filippo Pelizzaro 5, Angelo Sangiovanni 6, Giuseppe Cabibbo 7, Giorgia Ghittoni 8, Mariella Di Marco 9, Francesco Giuseppe Foschi 10, Maria Guarino 11, Elisabetta Biasini 12, Carlo Saitta 13, Claudia Campani 14, Gianluca Svegliati-Baroni 15, Antonio Gasbarrini 16, Maurizia Rossana Brunetto 17, Donatella Magalotti 18, Francesco Azzaroli 19, Andrea Mega 20, Rodolfo Sacco 21, Gerardo Nardone 22, David Sacerdoti 23, Alberto Masotto 24, Gianpaolo Vidili 25, Laura Bucci 4 26, Alessandro Vitale 27, Franco Trevisani 4 26; Italian Liver Cancer (ITA.LI.CA) group

 

Collaborators

Italian Liver Cancer (ITA.LI.CA) group: 

Maurizio Biselli, Lorenzo Lani, Benedetta Stefanini, Valentina Santi, Alessandro Granito, Fabio Piscaglia, Francesco Tovoli, Luca Muratori, Francesca Benevento, Fabio Farinati, Gloria Allegrini, Calogero Cammà, Ciro Celsa, Paolo Giuffrida, Carmelo Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Roberta Ciccia, Alessandro Grova, Mauro Salvato, Valentina Adotti, Stefano Gitto, Fabio Marra, Martina Rosi, Vittoria Bevilacqua, Alberto Borghi, Fabio Conti, Anna Chiara Dall'Aglio, Giorgio Ercolani, Federica Mirici, Laura Schiadà, Chiara Scorzoni, Giulia Scandali, Francesca Romana Ponziani, Gabriele Missale, Andrea Olivani, Mario Capasso, Valentina Cossiga, Filomena Morisco, Ester Marina Cela, Antonio Facciorusso, Valentina Lauria, Giorgio Pelecca, Fabrizio Chegai, Fabio Coratella, Mariano Ortenzi, Serena Dell'Isola, Roberto Filomia, Concetta Pitrone, Giovanni Raimondo, Assunta Sauchella, Elton Dajti, Federico Ravaioli, Filippo Oliveri, Gabriele Ricco, Veronica Romagnoli, Alessandro Inno, Fabiana Marchetti, Pietro Coccoli, Antonio Malerba, Alberta Cappelli, Cristina Mosconi, Matteo Renzulli, Luca Marzi
 
116.HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States
 

Hepatology. 2024 Jun 19. doi: 10.1097/HEP.0000000000000953. Online ahead of print.

 

Hashem B El-Serag 1 2, Qingchun Jin 3, Tayob Nabihah 3, Emad Salem 1, Michelle Luster 1, Abeer Alsarraj 2, Saira Khaderi 1, Amit G Singal 4, Jorge A Marrero 5, Sumeet K Asrani 6, Fasiha Kanwal 1 2
 
117.Steatohepatitic Hepatocellular Carcinoma:A New Approach to Classifying Morphological Subtypes of Hepatocellular Carcinoma
 

Hum Pathol. 2024 Jun 12:S0046-8177(24)00108-4. doi: 10.1016/j.humpath.2024.06.007.Online ahead of print.

 

Gwyneth S T Soon 1, Francesco Callea 2, Alastair D Burt 3, Sam Cook 3, Luigi Terracciano 4, Caner Ercan 5, Hans-Peter Dienes 6, Zachary D Goodman 7, Eve A Roberts 8, Andrew D Clouston 9, Annette S H Gouw 10, David E Kleiner 11, Young Nyun Park 12, Taek Chung 13, Peter Schirmacher 14, Dina Tiniakos 15, Konstantina Dimopoulou 16, Achim Weber 17, Katharina Endhardt 17, Michael Torbenson 18
 
118.A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation
 

Dig Dis Sci. 2024 Jun 13. doi: 10.1007/s10620-024-08470-1. Online ahead of print.

 

Sophie Hansen 1 2, Richard Gilroy 2, Ian Lindsay 3, John R Doty 4, Ross A Butschek 5, Christopher J Danford 6
 
119.Is home-based, virtually delivered, group exercise feasible and acceptable for older patients with hepatocellular carcinoma? A non-randomised feasibility study (TELEX-Liver Cancer)
 

BMJ Open. 2024 Jun 12;14(6):e082155. doi: 10.1136/bmjopen-2023-082155.

 

Kate Hallsworth 1 2 3, Misti V McCain 4 3 5, Roisin Fallen-Bailey 6, Morven C Brown 5 7, Samuel T Orange 4 5 7 8, Helen L Reeves 4 2 3 5
 
120.Tumor Mutational Burden from Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance: An Emerging Biomarker for Surveillance
 

Ann Surg. 2024 Jun 11. doi: 10.1097/SLA.0000000000006386. Online ahead of print.

 

Chase J Wehrle 1, Hanna Hong 1, Suneel Kamath 2, Andrea Schlegel 1, Masato Fujiki 1, Koji Hashimoto 1, David Choon Hyuck Kwon 1, Charles Miller 1, R Matthew Walsh 1, Federico Aucejo 1
 
121.EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
 

Diabetologia. 2024 Jun 13. doi: 10.1007/s00125-024-06196-3. Online ahead of print.

 

European Association for the Study of the Liver; European Association for the Study of Diabetes; European Association for the Study of Obesity; Clinical Practice Guideline Panel
 
122.Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel
 

J Vasc Interv Radiol. 2024 Jun;35(6):818-824. doi: 10.1016/j.jvir.2024.02.017.

 

Lindsay M Thornton 1, Nadine Abi-Jaoudeh 2, Howard J Lim 3, Katerina Malagari 4, Benjamin Oren Spieler 5, Masatoshi Kudo 6, Richard S Finn 7, Riccardo Lencioni 8, Sarah B White 9, Nima Kokabi 10, D Rohan Jeyarajah 11, Prosanto Chaudhury 12, David Liu 13
 
123.Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review
 

Chin Clin Oncol. 2024 May 19:cco-23-140. doi: 10.21037/cco-23-140. Online ahead of print.

 

Madeleine L Hall 1, Sweet Ping Ng 2, Umbreen Hafeez 3, Niall Tebbutt 4, Marie Sinclair 5, Farshad Foroudi 6, Michael Chao 6, Richard Khor 6
 
124.Interventional radiology meets immuno-oncology for hepatocellular carcinoma
 

J Hepatol. 2024 Jun;80(6):967-976. doi: 10.1016/j.jhep.2022.08.003.Epub 2022 Aug 19.

 

Riad Salem 1, Tim F Greten 2
 
125.Metformin as adjuvant treatment in hepatitis C virus infections and associated complications
 

Am J Med Sci. 2024 May 1:S0002-9629(24)01213-8.doi: 10.1016/j.amjms.2024.04.019. Online ahead of print.

 

Dylan Landis 1, Alex Sutter 1,